What You Need To Know About Belviq – Weight-Loss Medication
Most weight-loss medications have long been considered unsafe for patients struggling with obesity with an existing or higher risk of heart problems. Thankfully, there is one medication that can assist, without an increase in cardiac complications: Belviq.
Belviq is a “wonder-drug” that can help almost anyone lose weight. It is the first and only weight-loss medication with long-term cardiovascular safety for people who are obese or overweight; people who have a statistically higher risk of heart attacks and strokes.
Belviq can also lead to slight improvements in several risk factors that cause heart disease, including blood sugar levels, heart rate, blood pressure, and the amount of blood fats known as triglycerides.
After three years of rigorous testing of 12,000 obese and overweight patients with serious risk of heart problems, research showed almost no difference between the rates of major heart problems of patients using Belviq, and patients using a placebo. Patients who took Belviq, combined with a healthier diet and increased exercise, lost a yearly average of 9.3 pounds, and 39% of patients lost over 5% body weight, with 15% losing more than 10% body weight. Compare that with the placebo group who only lost a yearly average of 3 pounds, while 17% lost over 5% body weight, and 5% of patients lost over 10%.
Belviq helps patients who are overweight to lose weight, and also keep it off. This ultimately leads to a healthier lifestyle that also lessens the myriad of health risks associated with obesity. Belviq is in a class of drugs identified as serotonin receptor agonists, which means it works by affecting the part of the brain which controls appetite. Using Belviq should be combined with a program of doctor-approved exercise, a proactive change in behavior, and a reduced-calorie diet.
Belviq is usually taken by mouth twice per day with or without food. It is important not to consume higher doses or take it more often than prescribed, as it won’t increase the amount or speed of your weight loss, but it will increase your risk of side effects. If you do not see a reduction in your weight with 12 weeks of treatment, Belviq may not be beneficial medication for you and your doctor may tell you to cease using it.
The most common side effects when beginning use of Belviq include cottonmouth, nausea, constipation, headaches, dizziness, or lethargy. Consult with your doctor if they persist or worsen. You should immediately contact your doctor if Belviq causes any serious side effects, including easy bleeding or bruising, enlarged breasts, abnormal breast milk, shaking or twitching muscles, shortness of breath, irregular heartbeat, swelling extremities, unexplained fever, and changes in mood such as confusion, depression, suicidal thoughts, agitation, or difficulty with attention and/or memory.
While rare, it is possible for males taking Belviq to experience a painful and/or prolonged erection, often lasting four hours or more. If this happens, cease taking the drug and immediately contact medical professionals, as it may cause permanent problems. Serious allergic reaction to this drug is also rare, but you should seek immediate medical attention if you have any allergy symptoms such as itchiness or rashes, severe dizziness, breathing trouble, or any kind of swelling, especially of the face, tongue, or throat.
This is not a complete list of all possible side effects of Belviq, so contact your doctor if you experience anything which is not mentioned above to discuss.
Talk to your doctor before using Belviq, especially if your medical history includes heart problems, diabetes, kidney problems, liver problems, and any condition that increases the risk of prolonged or painful erections such as leukemia, sickle cell anemia, Peyronie’s disease, or multiple myeloma.
Belviq may contain inactive ingredients that cause allergic reactions or other problems, such as dizziness, slow thought processes, or increased reaction time, and consumption of alcohol, marijuana, or illicit drugs can worsen these effects. Some medications are also known to negatively interact with Belviq, such as those containing Cabergoline and Dextromethorphan, among others.
If you are diabetic, be aware that Belviq may affect blood sugar levels. Because of possible risks to unborn and infant children, Belviq should not be used during pregnancy or inception, and breast-feeding is also not recommended as it is unknown if this medication is passed through breast-milk.
Belviq is the only weight-loss drug on the market today that helps obese or overweight patients to lose weight without causing any adverse cardiovascular reactions. To find out how Belviq can help you lose weight effectively, get in touch with us today.